MACROGENICS, INC. Increase (Decrease) in Deferred Revenue
MACROGENICS, INC. (MGNX) reported Increase (Decrease) in Deferred Revenue of $13.40 million for the 12-month period ending 2018-12-31, per its 10-K filed 2019-02-26.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInDeferredRevenue · last filed 2019-02-26
- MACROGENICS, INC. increase (decrease) in deferred revenue for the quarter ending 2018-12-31 was $19.21M, a 108.85% increase year-over-year.
- MACROGENICS, INC. increase (decrease) in deferred revenue for the quarter ending 2018-09-30 was -$2.44M.
- MACROGENICS, INC. increase (decrease) in deferred revenue for the quarter ending 2018-06-30 was -$1.94M.
- MACROGENICS, INC. increase (decrease) in deferred revenue for the quarter ending 2018-03-31 was -$1.44M.
- MACROGENICS, INC. increase (decrease) in deferred revenue for fiscal 2018 was $13.40M, a 105.19% increase from fiscal 2017.
- MACROGENICS, INC. increase (decrease) in deferred revenue for fiscal 2017 was $6.53M.
- MACROGENICS, INC. increase (decrease) in deferred revenue for fiscal 2016 was -$4.19M.
- MACROGENICS, INC. increase (decrease) in deferred revenue for fiscal 2015 was -$12.22M, a 468.50% decline from fiscal 2014.
| Period end | Increase (Decrease) in Deferred Revenue 3 month | Increase (Decrease) in Deferred Revenue 3 month as first filed | Increase (Decrease) in Deferred Revenue 6 month | Increase (Decrease) in Deferred Revenue 9 month | Increase (Decrease) in Deferred Revenue 9 month as first filed | Increase (Decrease) in Deferred Revenue 12 month | Increase (Decrease) in Deferred Revenue 12 month as first filed |
|---|---|---|---|---|---|---|---|
| 2018-12-31 | $19.21M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $16.78M derived: sum of 2 quarters · filed 2019-02-26 | $14.84M derived: sum of 3 quarters · filed 2019-02-26 | $13.40M 10-K · filed 2019-02-26 | |||
| 2018-09-30 | -$2.44M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | -$4.37M derived: sum of 2 quarters · filed 2018-11-07 | -$5.81M 10-Q · filed 2018-11-07 | $3.39M derived: sum of 4 quarters · filed 2019-02-26 | |||
| 2018-06-30 | -$1.94M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | -$3.37M 10-Q · filed 2018-08-07 | $5.83M derived: sum of 3 quarters · filed 2019-02-26 | $5.03M derived: sum of 4 quarters · filed 2019-02-26 | |||
| 2018-03-31 | -$1.44M 10-Q · filed 2018-05-07 | $7.76M derived: sum of 2 quarters · filed 2019-02-26 | $6.96M derived: sum of 3 quarters · filed 2019-02-26 | $6.16M derived: sum of 4 quarters · filed 2019-02-26 | |||
| 2017-12-31 | $9.20M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | $8.40M derived: sum of 2 quarters · filed 2019-02-26 | $7.60M derived: sum of 3 quarters · filed 2019-02-26 | $6.53M 10-K · filed 2019-02-26 | |||
| 2017-09-30 | -$800.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-07 | -$1.60M derived: sum of 2 quarters · filed 2018-11-07 | -$2.67M 10-Q · filed 2018-11-07 | -$1.94M derived: sum of 4 quarters · filed 2019-02-26 | |||
| 2017-06-30 | -$801.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-07 | -$1.87M 10-Q · filed 2018-08-07 | -$1.14M derived: sum of 3 quarters · filed 2019-02-26 | -$2.88M derived: sum of 4 quarters · filed 2019-02-26 | |||
| 2017-03-31 | -$1.06M 10-Q · filed 2018-05-07 | -$336.00K derived: sum of 2 quarters · filed 2019-02-26 | -$2.08M derived: sum of 3 quarters · filed 2019-02-26 | -$3.36M derived: sum of 4 quarters · filed 2019-02-26 | |||
| 2016-12-31 | $729.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26 | -$1.01M derived: sum of 2 quarters · filed 2019-02-26 | -$2.30M derived: sum of 3 quarters · filed 2019-02-26 | -$4.19M 10-K · filed 2019-02-26 | |||
| 2016-09-30 | -$1.74M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | -$3.03M derived: sum of 2 quarters · filed 2017-11-08 | -$4.92M 10-Q · filed 2017-11-08 | -$5.47M derived: sum of 4 quarters · filed 2018-02-27 | |||
| 2016-06-30 | -$1.29M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-02 | -$3.18M 10-Q · filed 2017-08-02 | -$3.73M derived: sum of 3 quarters · filed 2018-02-27 | -$7.59M derived: sum of 4 quarters · filed 2018-02-27 | |||
| 2016-03-31 | -$1.89M 10-Q · filed 2017-05-03 | -$2.45M derived: sum of 2 quarters · filed 2018-02-27 | -$6.30M derived: sum of 3 quarters · filed 2018-02-27 | -$10.17M derived: sum of 4 quarters · filed 2018-02-27 | |||
| 2015-12-31 | -$555.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-27 | -$4.41M derived: sum of 2 quarters · filed 2018-02-27 | -$8.27M derived: sum of 3 quarters · filed 2018-02-27 | -$12.22M 10-K · filed 2018-02-27 | |||
| 2015-09-30 | -$3.86M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-02 | -$7.72M derived: sum of 2 quarters · filed 2016-11-02 | -$11.67M 10-Q · filed 2016-11-02 | -$15.62M derived: sum of 4 quarters · filed 2017-02-28 | |||
| 2015-06-30 | -$3.86M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-03 | -$7.81M 10-Q · filed 2016-08-03 | -$11.76M derived: sum of 3 quarters · filed 2017-02-28 | -$21.69M derived: sum of 4 quarters · filed 2017-02-28 | |||
| 2015-03-31 | -$3.95M 10-Q · filed 2016-05-04 | -$7.90M derived: sum of 2 quarters · filed 2017-02-28 | -$17.82M derived: sum of 3 quarters · filed 2017-02-28 | -$10.05M derived: sum of 4 quarters · filed 2017-02-28 | |||
| 2014-12-31 | -$3.95M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-28 | -$13.88M derived: sum of 2 quarters · filed 2017-02-28 | -$6.11M derived: sum of 3 quarters · filed 2017-02-28 | $3.32M 10-K · filed 2017-02-28 | |||
| 2014-09-30 | -$9.93M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-04 | -$2.16M derived: sum of 2 quarters · filed 2015-11-04 | $7.27M 10-Q · filed 2015-11-04 | $4.56M derived: sum of 4 quarters · filed 2016-02-29 | |||
| 2014-06-30 | $7.77M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-05 | $17.19M 10-Q · filed 2015-08-05 | $14.49M derived: sum of 3 quarters · filed 2016-02-29 | $7.29M derived: sum of 4 quarters · filed 2016-02-29 | |||
| 2014-03-31 | $9.42M 10-Q · filed 2015-05-06 | $9.42M 10-Q · filed 2014-05-06 | $6.72M derived: sum of 2 quarters · filed 2016-02-29 | -$481.00K derived: sum of 3 quarters · filed 2016-02-29 | -$7.59M derived: sum of 4 quarters · filed 2016-02-29 | ||
| 2013-12-31 | -$2.71M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | -$9.90M derived: sum of 2 quarters · filed 2016-02-29 | -$17.01M derived: sum of 3 quarters · filed 2016-02-29 | -$16.68M 10-K · filed 2016-02-29 | -$16.68M 10-K · filed 2014-03-20 | ||
| 2013-09-30 | -$7.20M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-12 | -$14.31M derived: sum of 2 quarters · filed 2014-11-12 | -$13.97M 10-Q · filed 2014-11-12 | -$13.97M 10-Q · filed 2013-11-12 | $3.16M derived: sum of 4 quarters · filed 2015-03-03 | ||
| 2013-06-30 | -$7.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-05 | -$6.77M 10-Q · filed 2014-08-05 | $10.35M derived: sum of 3 quarters · filed 2015-03-03 | ||||
| 2013-03-31 | $339.00K 10-Q · filed 2014-05-06 | $17.46M derived: sum of 2 quarters · filed 2015-03-03 | |||||
| 2012-12-31 | $17.13M derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-03 | -$10.81M 10-K · filed 2015-03-03 | -$10.81M 10-K · filed 2014-03-20 | ||||
| 2012-09-30 | -$27.94M 10-Q · filed 2013-11-12 | ||||||
| 2011-12-31 | -$4.28M 10-K · filed 2014-03-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cue Biopharma, Inc. (CUE) | United States | $0.243B | -1.01 |
| Entrada Therapeutics, Inc. (TRDA) | United States | $0.243B | -1.73 |
| Pyxis Oncology, Inc. (PYXS) | United States | $0.244B | |
| Camp4 Therapeutics Corp (CAMP) | United States | $0.240B | -2.12 |
| Lyell Immunopharma, Inc. (LYEL) | United States | $0.248B | -1.32 |
| Sionna Therapeutics, Inc. (SION) | United States | $0.236B | -20.37 |
| SIGA TECHNOLOGIES INC (SIGA) | United States | $0.234B | -93.33 |
| Cartesian Therapeutics, Inc. (RNAC) | United States | $0.231B | -2.04 |
| Keros Therapeutics, Inc. (KROS) | United States | $0.229B | -2.55 |
| Akebia Therapeutics, Inc. (AKBA) | United States | $0.255B | -10.35 |